Investigational Site Number : 7240002

Barcelona 08041

1 studies enrolling now · 6 studies all time

What they study most

Dermatitis Atopic, Glycogen Storage Disease Type II;Pompe's Disease, Polyneuropathy, Inflammatory Demyelinating, Chronic, Relapsing Multiple Sclerosis, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

Studies at this site

• Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP — Enrolling by invitation
• Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis — Completed
• Observational Evaluation of Atopic Dermatitis in Pediatric Patients — Running, not enrolling
• Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease — Completed
• Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus — Completed
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early